HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.

AuthorsV Singh, K Sud, B R Mittal, H S Kohli, K L Gupta, V Sakhuja
JournalTransplantation proceedings (Transplant Proc) Vol. 34 Issue 8 Pg. 3191-2 (Dec 2002) ISSN: 0041-1345 [Print] United States
PMID12493416 (Publication Type: Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Hemoglobins
  • Cyclosporine
  • Creatinine
  • Azathioprine
Topics
  • Angiotensin-Converting Enzyme Inhibitors (adverse effects, therapeutic use)
  • Azathioprine (adverse effects, therapeutic use)
  • Blood Pressure (physiology)
  • Creatinine (blood)
  • Cyclosporine (adverse effects, therapeutic use)
  • Erythrocyte Count
  • Female
  • Graft Rejection (epidemiology)
  • Hematocrit
  • Hemoglobins (analysis)
  • Humans
  • Kidney Transplantation (adverse effects, physiology)
  • Male
  • Polycythemia (drug therapy, epidemiology)
  • Postoperative Complications (drug therapy, epidemiology)
  • Prospective Studies
  • Renal Artery Obstruction (epidemiology)
  • Retrospective Studies
  • Risk Factors
  • Smoking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: